Home | Join Now | Print Page | Report Abuse | Sign In
2019 ALNE Conference Agenda
Share |

MPhA 2019 Banner

Agenda

Thursday, October 3


7:30 - 8:15 am

Registration & Breakfast with Vendors



8:15 - 8:30 am

Welcome Address

Craig Else, PharmD, MHSA System Executive Director COO, IntegraDose Compounding Services Fairview Health Services, MPhA President



8:30 - 9:45 am

Keynote World Café

Celebrate the Past & Envision Your Future

Craig Else, PharmD, MHSA System Executive Director COO, IntegraDose Compounding Services Fairview Health Services, MPhA President

Session Info

This World Café session will feature discussion with current practicing attendees and pharmacists who have retired. We will highlight the changes and evolution of pharmacy, and the perspective that comes with experience, to reflect on the future of pharmacy. Newer practitioners may be evolving and inventing new ways to practice, but it is important to understand and appreciate the pioneers and change agents that have helped move pharmacy to our current state. Our more experienced pharmacists will also share how new ideas may actually be really good (or bad) old ideas re-entering our practice. Leaders in pharmacy practice who have retired will also share their perspective now that they are not in the daily grind of pharmacy, and how that has (or has not) changed their feelings for pharmacy and its future. This session will allow attendees to discuss and share their ideas and vision for the profession and practice of pharmacy, and gain from the experience and perspective of a past generation of leaders who are still passionate about the profession.

After participating in this knowledge-based program, pharmacists should be able to:

  • Explain the reason you personally chose pharmacy as a profession, and how it integrates into a personal identify.
  • Discuss barriers encountered in practice, and how those were overcome.
  • Discuss changes in the profession during your time practicing as a pharmacist.
  • Compare and contrast historical and current practice to understand where pharmacy as a profession has been, and is moving.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Explain how you personally arrived at pharmacy technician as a profession.
  • Discuss barriers and changes/growing opportunity you have seen in practice as a technician as pharmacist roles evolve.
  • Compare historical and current practice as a pharmacy technician, and potential growth areas.

ACPE# 0102-0000-19-001-L04-P&T - 1.25 credits - Knowledge




9:45 - 10:15 am

Break with Vendors



10:15 am - 12:15 pm

Breakout Sessions

Track 1 - Clinical Pearls

Migraine Update

Natalie Roy, PharmD, Medication Therapy Management Pharmacist, Fairview Pharmacy Services

Session Info

Migraines are among the most common and disabling neurologic conditions, and they result in significant financial burden in the United States. In recent years, the treatment of migraines has evolved with approval of the first medication class specific to migraines, the Calcitonin gene-related peptide (CGRP) inhibitors. Previously, clinicians were limited to borrowing medications from other indications, such as antidepressants and antihypertensives, to treat their patients with migraines. In this session, we will discuss the role of the CGRP inhibitors in the context of migraine management, as well as other management strategies for prevention and treatment of migraines.

After participating in this knowledge-based program, pharmacists should be able to:

  • Differentiate episodic and chronic migraine by listing criteria for diagnosis of each type, including concomitant symptoms and frequency of headaches.
  • Determine appropriateness of therapy for migraine prevention and develop a treatment plan for patient cases.
  • Explain the mechanism and place in therapy for the Calcitonin gene-related peptide (CGRP) inhibitors.
  • Define medication overuse in the context of migraine management.
  • List evidence-based abortive therapies based on the 2018 American Headache Society Guidelines.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Identify the three possible symptoms associated with migraines.
  • List at least five medications that can be used to prevent migraines.
  • Describe the consequences of medication overuse headaches.

ACPE# 0102-0000-19-002-L01-P&T - .5 credits - Knowledge



Track 1 - Clinical Pearls

Interpreting Culture Results: Common Pitfalls and Clinical Pearls

Krista Gens, PharmD, BCPS-AQ ID, DPLA, Infectious Diseases Clinical Pharmacy Coordinator, Abbott Northwestern Hospital, part of Allina Health

Session Info

Interpreting culture results can be challenging for pharmacists and even physicians. Laboratory reports presume an inherent baseline knowledge that may not be readily apparent, and not all options on a susceptibility report are equally recommended. There are tips and tools available to help with culture result analysis.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify organisms that are commonly considered contaminants in certain cultures. Recognize common yet inappropriate susceptibility assumptions that can lead to treatment failure.
  • List resources that can assist in culture interpretation.
  • Identify organisms that are commonly considered contaminants in certain cultures.
  • Recognize common yet inappropriate susceptibility assumptions that can lead to treatment failure.
  • List resources that can assist in culture interpretation.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Identify organisms that are commonly considered contaminants in certain cultures.
  • Recognize common yet inappropriate susceptibility assumptions that can lead to treatment failure.
  • List resources that can assist in culture interpretation.

ACPE# 0102-0000-19-003-L04-P&T - .5 credits - Knowledge



Track 1 - Clinical Pearls

Blood Thinners, Bridging, and Bleeding...Oh My!

Richard Mullvain, RPh, BCCP, BCPS (AQ-Cardiology), CCCC, Clinical Pharmacist, Essentia Health Heart & Vascular Center - Duluth, MN

Session Info

A current update on the peri-procedural management of oral anticoagulants and antiplatelet agents.

After participating in this knowledge-based program, pharmacists should be able to:

  • Apply new comprehension on proper peri-procedural management of oral anticoagulants in patient care.
  • Evaluate the patient health benefits of the proper peri-procedural management of antiplatelet agents
  • Examine and evaluate new treatments and strategies appropriate for life-threatening bleeding related to oral anticoagulants.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Name at least three oral anticoagulant medications.
  • Discuss proper peri-procedural management of oral anticoagulants.

ACPE# 0102-0000-19-004-L01-P&T - .5 credits - Knowledge




10:15 - 11:15 am

Track 2 - Pharmacy Practice/Mgmt

Value-Based Payment and Quality Metrics: Where We Are and Need to Be

Nick Dorich, PharmD, Director, Client Services, Pharmacy Quality Solutions, Inc.

Session Info

While quality measures have existed in health care for many years, it is still is a new landscape for community pharmacy practice. Hear about expanding areas of medication-related quality measures and how pharmacy staff members can collaborate to address patient care opportunities.

After participating in this knowledge-based program, pharmacists should be able to:

  • Review medication-related quality measures that pharmacies can impact.
  • Outline how to best position your pharmacy for success in quality improvement programs.
  • Review methods to help prioritize work so your team can quickly impact measures and become proactive vs. reactive.
  • Outline a pharmacy-specific action plan to positively impact performance.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Describe what medication-related quality measures are.
  • Discuss some methods to help prioritize work so your team can quickly impact measures and become proactive vs. reactive.

ACPE# 0102-0000-19-005-L04-P&T - 1.0 credits - Knowledge



Track 3 - Student & New Practitioner

Reaching to Thrive: Moving Beyond Survival Mode

Stephanie Swanson, PharmD, Teaching Specialist, University of Minnesota College of Pharmacy

Session Info

During this session participants will be introduced to the topics of vulnerability, authenticity and empathy and how each can influence their professional lives. Through individual reflection and small group discussion, participants will identify where these factors have impacted their career and how they can promote thriving at work over day-to-day survival. At the end of the session, participants will create a mantra related to vulnerability, authenticity and empathy to move toward a higher level of professional well-being.

After participating in this knowledge-based program, pharmacists should be able to:

  • Discuss how vulnerability, authenticity and empathy contribute to thriving in your life and career.
  • Personally reflect on these concepts within your current life and how they have impacted your career as a pharmacist.
  • Create a mantra to focus on progressing in an aspect of vulnerability, authenticity or empathy to move toward thriving in your work.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Describe how vulnerability, authenticity and empathy contribute to thriving in your life and career.
  • Personally reflect on these concepts within your current life and how they have impacted your career as a pharmacy technician.
  • Create a mantra to focus on progressing in an aspect of vulnerability, authenticity or empathy to move toward thriving in your work.

ACPE# 0102-0000-19-007-L04-P&T - 1.0 credits - Knowledge




11:15 am - 12:15 pm

Track 2 - Pharmacy Practice/Mgmt

Reimbursement Challenges: Strategies and Updates

Jason Miller, PharmD, Clinical Program Manager, Coborn's, Inc.; Jeff Lindoo, BS Pharmacy, MPhA Past President, Thrifty White Pharmacy; Buck Humphrey, Minnesota Pharmacy Alliance Lobbyist, Capitol Hill Strategies; and Chad Hope, PharmD, Deputy Director of Purchasing and Services, DHS

Session Info

An overview of current steps being implemented in a retail pharmacy to address pay-for-performance contracts and DIR fees.

After participating in this knowledge-based program, pharmacists should be able to:

  • Better formulate programs and initiatives to help mitigate the risk of DIR fees and take advantage of pay-for-performance contracting.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Describe what DIR fees are and what circumstances would cause the pharmacy to need to pay them.
  • Explain the meaning of pay-for-performance contracting.

ACPE# 0102-0000-19-006-L04-P&T - 1.0 credits - Knowledge



Track 3 - Preceptor Development

Developing Cultural Competency: A Lifelong Process Incorporated in Precepting Students

Raquel Rodriguez, BS Pharm, PhD, Director, Experiential Education, University of Minnesota, College of Pharmacy-Twin Cities and Mary McGuiggan, PharmD, BCGP, Director, Preceptor Development, University of Minnesota, College of Pharmacy

Session Info

Cultural competency is a process that requires lifelong learning. This session will present data that validate the need to continue the support for pharmacists/preceptors/pharmacy technicians regarding cultural competency. The participants will create plans to enhance their own cultural competency development, student experiences as well as patient interactions.

After participating in this knowledge-based program, pharmacists should be able to:

  • List experiences of pharmacy preceptors when providing pharmacy services to a culturally diverse population.
  • Describe cultural sensitivity/awareness as vital to the Pharmacist's Patient Care Process.
  • Understand how the preceptor roles of instructing, modeling, coaching, and facilitating impact cultural competence development in students.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • List some examples of experiences with a culturally diverse population when providing pharmacy services.
  • Describe cultural sensitivity/awareness as vital to the Pharmacist's Patient Care Process.
  • Describe how pharmacy technicians can model, coach, and facilitate the development of cultural competence in students.

ACPE# 0102-0000-19-008-L04-P & T - 1.0 credits - Knowledge



12:15 - 1:45 pm

Lunch & Networking with Exhibitors



1:45 - 2:30 pm

General Session

Well-being and Resiliency: Learning to Surf

Amanda Brummel, PharmD, BCACP, VP, Clinical Services, Fairview

Session Info

As Jon Kabat-Zin states, "You can't stop the waves, but you can learn to surf." As health care providers, many waves come our way each day. In this session, we will begin the process of learning to surf. We will explore the connection between well-being and resilience, and understand how they can positively impact our lives. Together we will outline ways to build resilience and discuss self-care strategies to enhance resiliency and well-being.

After participating in this knowledge-based program, pharmacists should be able to:

  • Discuss well-being in the context in which health professionals live and work.
  • Discuss self-care strategies that enhance resiliency and mindful awareness.
  • Identify strategies you can implement to build resilience and develop a personalized action plan for self-care.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Describe well-being in the context in which health professionals live and work.
  • State self-care strategies that enhance resiliency and mindful awareness.
  • Identify strategies you can implement to build resilience and develop a personalized action plan for self-care.

ACPE# 0102-0000-19-009-L04-P & T - .75 credits - Knowledge



2:30 - 3:00 pm

Break with Vendors



3:00 - 4:00 pm

Breakout Sessions

Track 2 - Pharmacy Practice/Mgmt or Clinical

Pharmacy's Role in Treatment and Overall Care Management of Atopic Dermatitis

Tom Larson, PharmD, Professor, University of Minnesota, College of Pharmacy-Twin Cities, Department of Pharmaceutical Care & Health Systems

Session Info

The goal of this educational activity is to provide pharmacists with increased knowledge to fill practice gaps specific to the recognition, diagnosis, treatment, and overall care management of atopic dermatitis (AD).

After participating in this knowledge-based program, pharmacists should be able to:

  • Explain how to recognize and diagnose atopic dermatitis (AD).
  • Discuss recent advances in research that have led to a further understanding of the pathogenesis of AD.
  • Discuss the psychosocial impact of AD and quality of life issues.
  • Review current and emerging treatment options to manage care of AD based on efficacy and safety issues.
  • Discuss management of application site pain for topical agents and treatment pathways recommendations.

ACPE# 0102-0000-19-023-L01-P - 1.0 credits - Knowledge



3:00 - 5:00 pm

Roundtables

CMS Conditions of Participation: Current State and Impact on SNFs

Joe Litsey, PharmD, BCGP, Director of Consulting, Thrifty White Pharmacy

Session Info

The requirements for Long-Term Care (LTC) Facilities are the health and safety standards that LTC facilities must meet in order to participate in the Medicare or Medicaid Programs. This program will discuss pharmacy practice related updates to these requirements based on the significant changes in the industry as well as discussing implementation strategies for pharmacies and pharmacists in order to remain in compliance.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify how the updated CMS rules of participation for LTC facilities pertaining to medication use have impacted the LTC industry.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Discuss the updated CMS rules of participation for LTC facilities pertaining to medication use.

ACPE# 0102-0000-19-011-L03-P & T - .5 credits - Knowledge


The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction

Paull Rukavina, RPh, Fairview Medication Therapy Management Provider, Fairview Pharmacy Services

Session Info

This roundtable will review ADA/AACE glycemic control algorithms, CV trials/benefits of newer Type 2 antidiabetic medications (ADMs) and discuss clinical pearls of newer Type-2 ADMs.

After participating in this knowledge-based program, pharmacists should be able to:

  • Apply the most current Diabetes treatment algorithms (ADA/AACE).
  • Evaluate and Examine CV trials/benefits of newer Type 2 antidiabetic medications (ADMs).
  • Apply clinical pearls of newer Type 2 ADMs.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • List at least three medications used to management diabetes.
  • State what drugs are GLP-1s and Sglt-2s.
  • Discuss why these newer drugs have CV benefit.

ACPE# 0102-0000-19-012-L01-P & T - .5 credits - Knowledge


Dyslipidemia — Guideline Updates and New Therapies

Sean Stewart, PharmD, BCACP, Clinical Pharmacist, Park Nicollet

Session Info

This roundtable will troubleshoot common adverse effects to statin therapy using available tools and expert recommendations.

After participating in this knowledge-based program, pharmacists should be able to:

  • Perform a comprehensive risk assessment of a patient using the clinician-patient discussion format.
  • Determine the most appropriate lipid-lowering pharmacotherapy based patient-specific factors.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Discuss what risks are assessed in a patient prescribed a lipid-lowering medication.
  • List at least three lipid-lowering medications that are prescribed to patients.

ACPE# 0102-0000-19-013-L01-P & T - .5 credits - Knowledge


Fad Diets/Nutrition Interactions with Medication

Lisa Hursin, Bariatric Clinical Dietician, RD, LD, M Health Fairview and Vanessa Hauge, Registered Dietitian, Certified Diabetes Educator, RD, LD, M Health Fairview

Session Info

The presentation will review fad diets that have been prevalent in recent years. We will discuss potential adverse health outcomes, including possible nutrient deficiencies. We will also review nutrition and medication interactions that may occur. Our discussion will also focus on how to spot key claims of fad diets and the components of a healthy eating pattern for weight loss.

After participating in this knowledge-based program, pharmacists should be able to:

  • Name three fad diets that have been prevalent in the media in recent years.
  • Identify one potential adverse health-related outcome related to following a fad diet.
  • Identify one potential nutrient deficiency that may be related to following a fad diet.
  • Describe two nutrition and medication interactions related to foods that may be eaten in fad diets.
  • Be able to provide patients with three tips on how to spot key claims of fad diets to help avoid them.
  • Describe three key components of a healthy eating pattern for weight loss.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Name three fad diets that have been prevalent in the media in recent years.
  • Identify one potential adverse health-related outcome related to following a fad diet.
  • Describe two nutrition and medication interactions related to foods that may be eaten in fad diets.
  • Describe three key components of a healthy eating pattern for weight loss.

ACPE# 0102-0000-19-014-L04-P & T - .5 credits - Knowledge


New Aspirin Guidelines

Tiffany Cheng PharmD, MTM Pharmacist, Fairview Pharmacy Services and Michelle Tran, PharmD, MTM Pharmacist, Fairview

Session Info

There have been recent studies and guideline updates on use of aspirin in primary prevention. This session focuses on these new studies and changes in recommendations for aspirin use in primary prevention.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify new changes in aspirin recommendations in the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease and the 2019 ADA Guideline update.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Discuss the medication safety issues with overuse of aspirin.
  • Review the new recommendations for aspirin use in the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease and the 2019 ADA Guideline update.

ACPE# 0102-0000-19-015-L05-P & T - .5 credits - Knowledge


New Drug Update: Spravato, a Novel Antidepressant Nasal Spray

Kyle Walburg, Pharmacy Associate, University of Minnesota, College of Pharmacy-Twin Cities and Sarah Massey, PharmD, Second-Year Pharmaceutical Care Leadership Residents, University of Minnesota, College of Pharmacy-Twin Cities

Session Info

During this New Drug Update roundtable, attendees will learn about a novel antidepressant medication which is administered as a nasal spray. Together, we will review clinical trials leading to the approval of this medication as well as assess the indication, efficacy, safety, and convenience of treatment.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify the place in therapy in which this medication is indicated.
  • Explain the mechanism of action, use in special populations, contraindications, and side effects of the medications.
  • Compare the cost of similar antidepressant therapies available for patients.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Identify the place in therapy in which this medication is indicated.
  • Discuss the mechanism of action, use in special populations, contraindications, and side effects of the medications.
  • Discuss the cost of similar antidepressant therapies available for patients.

ACPE# 0102-0000-19-010-L01-P & T - .5 credits - Knowledge


Making Encounters More Meaningful

Randy McDonough, PharmD, M.S., BCGP, BCPS, FAPhA Co-owner, Director of Clinical Services Towncrest Pharmacy

Session Info

The focus of this roundtable is review of the practice changes needed in a community pharmacy to create the capacity to successfully provide enhanced services and improve patient therapeutic outcomes.

After participating in this knowledge-based program, pharmacists should be able to:

  • Justify reasons for moving toward a new model of patient care.
  • Summarize the practice changes needed to help you achieve high performance.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • List two reasons for moving toward a new model of patient care in the pharmacy.

ACPE# 0102-0000-19-016-L04-P & T - .5 credits - Knowledge


Medication Use in Obesity Management

Lauren Bloch, PharmD, Medication Therapy Management Pharmacist, University of Minnesota, College of Pharmacy-Twin Cities

Session Info

With obesity continuing to be a problem across the nation, weight management has become a hot topic. Although exercise and diet are the best ways to lose and maintain weight, recently, medical weight management has become more popular. This session will focus on medical weight management and provide information on how to best manage these patients.

After participating in this knowledge-based program, pharmacists should be able to:

  • Review weight management techniques available on the market.
  • Describe medication weight management options and when to utilize them.
  • Explain the pharmacology behind each of the medications.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Review weight management techniques currently available.
  • Name medications that can be used for medication weight management.
  • Describe potential uses of each medication.

ACPE# 0102-0000-19-017-L04-P & T - .5 credits - Knowledge


Pharmacogenomics: State of the Science and Application to Patient Care

Jeff Bishop, PharmD, MS, BCPP, FCCP, Associate Professor, University of Minnesota

Session Info

This will be a roundtable to discuss pharmacogenomics. Opportunities are available to discuss scientific principles and clinical application.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify resources to assist with the clinical evaluation of pharmacogenetic test information.
  • Describe the usefulness, limitations, and ethical considerations of pharmacogenetic testing in different clinical scenarios.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • List several pharmacogenetic tests being used currently.

ACPE# 0102-0000-19-018-L04-P & T - .5 credits - Knowledge


How CMM Can Improve Provider Work-Life

Kylee Funk, BCPS, Assistant Professor, University of Minnesota, College of Pharmacy-Twin Cities

Session Info

In this session, participants will learn about the current state of burnout among primary care providers. Results from recent research that demonstrates how CMM can positively impact provider work-life will be shared. Participants will then be led through a facilitated discussion to reflect on ways the study results might be applicable to their individual practices.

After participating in this knowledge-based program, pharmacists should be able to:

  • Describe how provider burnout impacts health care.
  • Reflect on ways their own practice may impact provider work-life.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Describe how provider burnout impacts health care.
  • Reflect on ways the practice of their team may impact provider work-life.

ACPE# 0102-0000-19-019-L04-P & T - .5 credits - Knowledge


Pharmacists' Role in Public Health: Battling STDs

Daniel Jude, PharmD, AAHIVP, CSP, Clinical Pharmacy Specialist, North Memorial Health

Session Info

Coming Soon!

ACPE# 0102-0000-19-020-L01-P & T - .5 credits - Knowledge


2019 Beers Criteria Update

Jordan Wolf, PharmD, BCGP, LTC Consultant Pharmacist, Thrifty White Pharmacy

Session Info

The Beers Criteria is a tool available to pharmacists that helps to identify potentially inappropriate medication use in older adults. While the tool has been around since 1991, the American Geriatric Society took over its maintenance in 2011, with the intent of updating its content every 3 years. The most recent update to the Beers criteria was published in The Journal of the American Geriatrics Society in April 2019. This session will review the intent and makeup of the Beers Criteria, as well as highlight the changes that occurred with the 2019 updates.

After participating in this knowledge-based program, pharmacists should be able to:

  • State the intent of the American Geriatric Society's Beers Criteria.
  • Identify the individual sections of the Beer's Criteria.
  • Recognize the changes that occurred with the 2019 Updates to the Beer's Criteria.

ACPE# 0102-0000-19-022-L01-P - .5 credits - Knowledge


USP Chapter <795> and Chapter <797> Update

Denise Frank, BPharm, RPh, FACA, Pharmacist/Consultant, Frank Consulting, LLC

Session Info

On June 3, 2019, USP published revisions of USP Chapter <795> Nonsterile Compounding, and USP Chapter <797> Sterile Compounding and published a new chapter, Chapter <825> Radiopharmaceuticals. There are significant revisions to both compounding chapters, <795> and <797>. Revisions include beyond-use dating, environment and sampling, training, categories of compounds, compounding allergenic extracts, and harmonization with USP <800> Hazardous Drugs. All of these (<795>, <797>, <800>, <825>) become official and enforceable on December 1, 2019. We will discuss the major revisions and what is needed to become compliant.

After participating in this knowledge-based program, pharmacists should be able to:

  • Analyze the changes to USP Chapter <795>.
  • Discuss the changes in beyond-use dating of nonsterile compounded preparations.
  • Analyze the changes to USP Chapter <797>
  • Explain the changes in beyond-use dating of sterile compounded preparations.
  • Explain the changes in environmental sampling for sterile compounding suites.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Identify the changes to USP Chapter <795>.
  • Discuss the changes in beyond-use dating of nonsterile compounded preparations.
  • Identify the changes to USP Chapter <797>
  • Discuss the changes in beyond-use dating of sterile compounded preparations.
  • Discuss the changes in environmental sampling for sterile compounding suites.

ACPE# 0102-0000-19-021-L07-P & T - .5 credits - Knowledge



5:00 - 6:00 pm

Awards Reception



6:00 pm

Music & Mingling with Kyle Walburg and Taylor Brooks


Friday, October 4


7:30 - 8:00 am

Registration & Breakfast with Vendors



8:00 - 8:15 am

Welcome

Craig Else, PharmD, MHSA System Executive Director COO, IntegraDose Compounding Services Fairview Health Services



8:15 - 9:00 am

Presentation

Where’s the Interface with Public Health and Pharmacists' Engagement in the Opioid and Substance Use Epidemic

Richard Moldenhauer, MS, LADC, ICADC, LPCC, Human Services Program Consultant/State Opioid Treatment Authority Representative | Behavioral Health Division I Minnesota Department of Human Services

Facilitated by: Brent Thompson, PharmD, Director of Pharmacy, FirstLight Health System and Laura Palombi, PharmD, MPH, MAT

Session Info

The role of pharmacists and technicians in public health has a long history of intersection, without enough effort to maximize the potential relationships. This session is intended to bring together a wide array of pharmacy and public health professionals to review, address, and strategize opportunities in addressing the nation's addiction crisis. After brief presentations from individuals actively engaged in the crisis, tabletop discussions will lead MPhA and our guest public health professionals in the beginnings of strategies and plans where the two can interface and join forces to address the addiction crisis here in Minnesota.

After participating in this knowledge-based program, pharmacists should be able to:

  • Review the current opioid and substance use disorder issue across the state of Minnesota.
  • Discuss current issues such as naloxone, syringe access, disposal sites, and authorized collector status.
  • Explain the importance of addressing this issue at the local level.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Review the current opioid and substance use disorder issue across the state of Minnesota.
  • Discuss current issues related to opioid and substance abuse including naloxone, syringe access, disposal sites, and authorized collector status.
  • State the importance of addressing the issue locally and how pharmacy technicians can assist with this issue.

ACPE# 0102-0000-19-024-L04-P & T - .75 credits - Knowledge



9:00 - 9:15 am

Break



9:15 - 10:15 am

Breakout Sessions

Track 1 - Public Health/Opioid

Where’s the Interface with Public Health and Pharmacists Engagement in the Opioid and Substance Use Epidemic

Kate Erickson, MSW, Opioid Overdose Prevention Director | Injury & Violence Prevention Section (temporary leave, returning 11/1/19), Injection Drug Use & Harm Reduction Planner | Infectious Disease Epidemiology Prevention and Control Division (1/9/2019-10/31/2019) Minnesota Department of Health

Cody Bassett, Opioid Prevention Naloxone Coordinator, Injury & Violence Prevention Section, Minnesota Department of Health

Sam Robertson, Drug Overdose Prevention Coordinator, BA, Minnesota Department of Health

Laura Palombi, PharmD, MPH, MAT

Brent Thompson, PharmD, Director of Pharmacy, FirstLight Health System

Session Info

The role of pharmacists and technicians in public health have a long history of intersection, without enough effort to maximize the potential relationships. This session is intended to bring together a wide array of pharmacy and public health professionals to review, address, and strategize opportunities in addressing the nation's addiction crisis. After brief presentations from individuals actively engaged in the crisis, tabletop discussions will lead MPhA and our guest public health professionals in the beginnings of strategies and plans where the two can interface and join forces to address the addiction crisis here in Minnesota.

After participating in this knowledge-based program, pharmacists should be able to:

  • Discuss the role of the Department of Health and Department of Health and Human Services.
  • Discuss the areas that pharmacy can assist in embracing public Health roles regarding opioid and substance use disorder.
  • Engage public health professionals and pharmacists to discuss ways to address local level opioid and substance use disorder in their community.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • State the role of the Department of Health and Department of Health and Human Services.
  • Discuss areas that pharmacy technicians can assist with opioid and substance use disorder.
  • Engage public health professionals and pharmacy technicians to discuss ways to address local level opioid and substance use disorder in their community.

ACPE# 0102-0000-19-025-L01-P & T - 1.0 credits - Knowledge



Track 2 - Pharmacy Practice/Management

Transforming Community Pharmacy Practice for Collaborative Care and Value-based Payment Models

Randy McDonough, PharmD, M.S., BCGP, BCPS, FAPhA Co-owner, Director of Clinical Services Towncrest Pharmacy

Session Info

This presentation will review community pharmacy practice transformations needed to create an environment that supports collaborative care and value-based payment models to ensure practice viability and sustainability in an evolving health care system.

After participating in this knowledge-based program, pharmacists should be able to:

  • Explain how community pharmacy practices can bring value to providers, payers, and other stakeholders involved in value-based models.
  • Describe the infrastructure changes needed in community pharmacy practice to meet the requirements of value-based models.
  • Describe examples of how community pharmacies are participating in value-based models.

ACPE# 0102-0000-19-026-L04-P - 1.0 credits - Knowledge




10:15 - 10:30 am

Break with Vendors



10:30 - 11:30 am

Breakout Sessions

Track 1 - Public Health/Opioid

Where’s the Interface with Public Health and Pharmacists Engagement in the Opioid and Substance Use Epidemic

Kate Erickson, MSW, Opioid Overdose Prevention Director | Injury & Violence Prevention Section (temporary leave, returning 11/1/19), Injection Drug Use & Harm Reduction Planner | Infectious Disease Epidemiology Prevention and Control Division (1/9/2019-10/31/2019) Minnesota Department of Health

Alison Molitor, MPH Drug Overdose Communications Coordinator | Injury & Violence Prevention Section Minnesota Department of Health

Laura Palombi, PharmD, MPH, MAT

Brent Thompson, PharmD, Director of Pharmacy, FirstLight Health System

Session Info

The role of pharmacists and technicians in public health have a long history of intersection, without enough effort to maximize the potential relationships. This session is intended to bring together a wide array of pharmacy and public health professionals to review, address and strategize opportunities in addressing the nation's addiction crisis. After brief presentations from individuals actively engaged in the crisis, tabletop discussions will lead MPhA and our guest public health professionals in the beginnings of strategies and plans where the two can interface and join forces to address the addiction crisis here in Minnesota.

After participating in this knowledge-based program, pharmacists should be able to:

  • Discuss the stigma that surrounds the opioid and substance abuse crisis.
  • Engage in group discussion on key topics associated with the opioid substance abuse crisis.
  • Review the learnings from the day's sessions.

ACPE# 0102-0000-19-027-L04-P - 1.0 credits - Knowledge



Track 2 - Pharmacy Practice/Management

Billing Boot Camp

Randy McDonough, PharmD, M.S., BCGP, BCPS, FAPhA Co-Owner, Director of Clinical Services Towncrest Pharmacy

Session Info

This presentation will review the financial considerations when offering new pharmacy services and new business models for receiving reimbursement for services.

After participating in this knowledge-based program, pharmacists should be able to:

  • Identify how to account for clinical pharmacist time and what services will bring in new income to help the pharmacy grow.
  • Discuss common financial considerations when offering any new pharmacy service.

ACPE# 0102-0000-19-028-L04-P - 1.0 credits - Knowledge




11:30 - 11:45 am

Break



11:45 am - 12:15 pm

Report from Public Health Sessions – Where's the Interface with Public Health and Pharmacists Engagement in the Opioid and Substance Use Epidemic

Brent Thompson, PharmD, Director of Pharmacy, FirstLight Health System and Laura Palombi, PharmD, MPH, MAT

Session Info

During this session participants will review the discussion that the groups had during the morning’s public health session. Issues to be discussed include naloxone, syringe access, disposal sites and other issues that arise during the morning session.

After participating in this knowledge-based program, pharmacists should be able to:

  • Review the learnings from the day’s previous sessions.
  • Discuss current issues such as naloxone, syringe access, disposal sites, and authorized collector status.
  • Discuss the areas that pharmacy can assist in embracing public health roles regarding opioid and substance use disorder.

ACPE# 0102-0000-19-029-L04-P - 1.0 credits - Knowledge



12:15 - 1:45 pm

Lunch and Closing Keynote

MN Pharmacy Advocacy Accomplishments and Plans

Michelle Aytay, RPh, CDE, Region #21 Clinical Services, Walgreens Co., MPhA Past President and Buck Humphrey, Minnesota Pharmacy Alliance Lobbyist, Capitol Hill Strategies

Session Info

In this session you will learn about the Minnesota Pharmacy Alliances (MPA) advocacy accomplishments and future plans and strategy for both legislative and regulatory action.

After participating in this knowledge-based program, pharmacists should be able to:

  • Analyze 2019 legislative successes.
  • Outline 2020 legislative initiatives.
  • Formulate strategic approach to accomplishing our goals.

After participating in this knowledge-based program, pharmacy technicians should be able to:

  • Review 2019 legislative successes.
  • Describe 2020 legislative initiatives.
  • Discuss strategic approach to accomplishing our goals.

ACPE# 0102-0000-19-030-L03-P & T - 1.25 credits - Knowledge


    Minnesota Pharmacists Association

     

    1000 Westgate Drive, Suite 252, St. Paul, MN 55114 | Phone: 651.697.1771 Fax: 650.290.2266 Email: info@mpha.org

    © 2019 MPhA. All Rights Reserved. Site Map. Email Deliverability.